Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M. Kohsaka S, et al. Among authors: wexler lh. Nat Genet. 2014 Jun;46(6):595-600. doi: 10.1038/ng.2969. Epub 2014 May 4. Nat Genet. 2014. PMID: 24793135 Free PMC article.
Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience.
Cosetti M, Wexler LH, Calleja E, Trippett T, LaQuaglia M, Huvos AG, Gerald W, Healey JH, Meyers PA, Gorlick R. Cosetti M, et al. Among authors: wexler lh. J Pediatr Hematol Oncol. 2002 Feb;24(2):101-5. doi: 10.1097/00043426-200202000-00009. J Pediatr Hematol Oncol. 2002. PMID: 11990694 Review.
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B. Gorlick R, et al. Clin Cancer Res. 2003 Nov 15;9(15):5442-53. Clin Cancer Res. 2003. PMID: 14654523 Review.
Methotrexate levels and outcome in osteosarcoma.
Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R. Zelcer S, et al. Among authors: wexler lh. Pediatr Blood Cancer. 2005 Jun 15;44(7):638-42. doi: 10.1002/pbc.20314. Pediatr Blood Cancer. 2005. PMID: 15704189
Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Wolden SL, Wexler LH, Kraus DH, Laquaglia MP, Lis E, Meyers PA. Wolden SL, et al. Among authors: wexler lh. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1432-8. doi: 10.1016/j.ijrobp.2004.08.005. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817347
Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.
Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P, Antonescu CR. Prakash S, et al. Among authors: wexler lh. J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87. doi: 10.1097/01.mph.0000157790.81329.47. J Pediatr Hematol Oncol. 2005. PMID: 15838387 Review.
243 results